2026 NPPES data Hematology & Oncology Physician NPI 1336249960 M.D., MPH
Verify on CMS →

Luis Camacho, M.D., MPH

Hematology & Oncology Physician in Houston, Texas.

This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 11,530 in Hematology & Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.

Federal data, no proprietary rating. We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
667
Medicare Part D claims · 83 beneficiaries · Hematology & Oncology Physician avg: 885
Generic prescribing
58%
generic claims · 42% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$30.1K
84 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

Luis Camacho, M.D., MPH filed 667 Medicare Part D claims in 2024 as a Hematology & Oncology Physician in Houston, Texas, prescribing 58% generic.

667
Part D claims, 2024
58%
generic prescribing
$30.1K
industry payments (Sunshine Act)
≥68th
pct by Part D claim volume (lower-bound band)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.

Federal trust snapshot

What official records show about Luis Camacho, M.D., MPH

Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.

  • Verified

    NPI registry status

    Active listing in the CMS National Provider Identifier Registry (NPI 1336249960), first enumerated 09/24/2006.

    Source: CMS NPPES

  • Reported

    Medicare Part D participation

    Filed 667 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.

    Source: CMS Part D Prescriber PUF

  • Reported

    Board certification signal

    Practices in an ABMS-board-eligible specialty; board certification not confirmed in federal records.

    Source: NUCC taxonomy + CMS participation heuristic

  • Reported

    Industry payment transparency

    $30.1K in reported industry payments (84 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.

    Source: CMS Open Payments

  • State context

    State board disciplinary context

    Texas statewide board action statistics are published annually — these figures describe aggregate state activity, not Luis Camacho, M.D., MPH's individual license status. Verify directly with the state medical board.

    Source: TMB annual report 2023

  • Not in federal data

    Individual sanction lookup

    PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.

    Source: State medical board / FSMB

This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.

CMS NPPES provider registry desk

NPI 1336249960 · Hematology & Oncology Physician

NPI-10 · ENUM-LEGACY · TAX-MID · RX-LIGHT · BOOK-LIGHT · PHOTO-ENUM

  • NPI-10 1336249960
  • ENUM-LEGACY 2006
  • TAX-MID 12K Hematology &
  • RX-LIGHT 667
  • BOOK-LIGHT 637 in Texas
  • PHOTO-ENUM Dwight McKee, M.D. · 2006

Luis Camacho, M.D., MPH's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2024, across all CMS prescribers nationally

667 ≥ 68th percentile 68% of 1,416,883 prescribers are in lower value bands

0–200: 679,947 prescribers (48%). Below this entry. 200–400: 188,835 prescribers (13%). Below this entry. 400–600: 95,866 prescribers (7%). Below this entry. 600–800: 60,107 prescribers (4%). This entry sits in this band. 800–1,000: 43,043 prescribers (3%). Above this entry. 1,000–1,200: 33,612 prescribers (2%). Above this entry. 1,200–1,400: 27,889 prescribers (2%). Above this entry. 1,400–1,600: 23,183 prescribers (2%). Above this entry. 1,600–1,800: 19,917 prescribers (1%). Above this entry. 1,800–2,000: 17,585 prescribers (1%). Above this entry. 2K+: 226,899 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.

Source CMS Medicare Part D Prescriber Public Use File · 2024

Board-eligible specialty (heuristic, not verified)

Luis Camacho, M.D., MPH practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about Luis Camacho, M.D., MPH?

Quality data not reported

NPI registry status

Active

Issued 09/24/2006

NPI 1336249960

Primary specialty

Hematology & Oncology Physician

Mid-sized

11,530 US NPIs in this specialty

Medicare Part D claims

667 25% vs specialty avg

2024 prescription claims

Specialty avg: 885

Specialty distribution in Texas

How Hematology & Oncology Physician compares to other specialties among Texas providers

Texas providers
Behavior Technician6%Student in an Organized Heal…5.3%Family Nurse Practitioner4.5%Professional Counselor4.4%Pharmacist4.3%Speech-Language Pathologist3.9%Hematology & Oncology Physic…0.1%
Largest specialties in Texas (% of in-state providers)

Board certification

Not published by CMS

CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Hematology & Oncology Physician. Verify directly:

How MIPS and board certification work

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Practice Address

6560 FANNIN STREET
Houston, TX 77030

Provider Details

NPI 1336249960
Specialty Hematology & Oncology Physician
Credentials M.D., MPH
Gender Male
NPI Issued 09/24/2006

Industry payments received (2024) - CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Luis Camacho, M.D., MPH. Source: openpaymentsdata.cms.gov.

Total received

$30.1K

Largest payer

Merck Sharp & Dohme LLC

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context - Texas TMB 2023 annual report

Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 - they are NOT specific to Luis Camacho, M.D., MPH. To verify Luis Camacho, M.D., MPH's current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

344
Total board actions, Texas 2023
Across 334 cases
4.47
Actions per 1,000 licensees
Texas statewide rate
probation
Most common action type
94 cases

TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

Luis Camacho, M.D., MPH - brand share 42.0%
Hematology & Oncology Physician average

42% brand-name claims vs 58% generic, on 667 2024 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2024.

667
Total Claims
$2.8M
Total Drug Cost
83
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
845.867
Total Day Supply
23,402
Brand vs Generic
42% brand / 58% generic
Brand Drug Cost
$2.3M
Generic Drug Cost
$469K
Opioid Claims
19 (2.8% rate)
Antibiotic Claims
16

Patient Demographics

Average Patient Age
73.3 years
Avg HCC Risk Score
2.45
Gender Split
46% female / 54% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.

What Luis Camacho, M.D., MPH prescribes most

Top Medicare Part D drugs by claim count, 2024

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2024
Drug Claims
Abiraterone Acetate
68
Prednisone
66
Eliquis
Apixaban
29
Keytruda
Pembrolizumab
27
Ondansetron Hcl
26
Cyramza
Ramucirumab
24
Sodium Chloride
0.9 % Sodium Chloride
21
Xgeva
Denosumab
21
Xarelto
Rivaroxaban
20
Famciclovir
18

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Hematology & Oncology Physician Overview

How Luis Camacho, M.D., MPH fits within the Hematology & Oncology Physician landscape nationally.

11,530
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
885
Avg Claims per Provider

Luis Camacho, M.D., MPH's 667 claims are below the specialty average of 885.

Nationwide Hematology & Oncology Physician peers with similar MIPS or enrollment year

Two federal-record peer sets for Camacho, both outside Texas so the neighborhoods are not geographic containment.

Same NPPES enumeration year (2006)

Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.

Nearby Hematology & Oncology Physician Providers in Texas

Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as Camacho.

One of 637 Hematology & Oncology Physician providers enrolled in Texas, 5 are shown here.

Compare Hematology & Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is Luis Camacho, M.D., MPH's specialty?
Luis Camacho, M.D., MPH specializes in Hematology & Oncology Physician and practices in Houston, Texas. Credentials: M.D., MPH.
How much does Luis Camacho, M.D., MPH prescribe under Medicare Part D?
In 2024, Luis Camacho, M.D., MPH wrote 667 Medicare Part D claims totaling $2.8M in drug costs for 83 beneficiaries.
Where is Luis Camacho, M.D., MPH located?
Luis Camacho, M.D., MPH is located at 6560 FANNIN STREET, Houston, TX, 77030. Phone: (713) 796-1200.
What is Luis Camacho, M.D., MPH's NPI number?
Luis Camacho, M.D., MPH's National Provider Identifier (NPI) is 1336249960, issued on 09/24/2006.
Does Luis Camacho, M.D., MPH prescribe more brand-name or generic drugs?
Luis Camacho, M.D., MPH's prescribing is 42% brand-name and 58% generic drugs by claim count, with $2.3M in brand drug costs.
Does Luis Camacho, M.D., MPH prescribe opioids?
Yes, Luis Camacho, M.D., MPH had 19 opioid claims in 2024 with an opioid prescribing rate of 2.8%.
How many Hematology & Oncology Physician providers are there in the US?
There are 11,530 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 885 Medicare Part D claims per year.
What drugs does Luis Camacho, M.D., MPH prescribe most often?
Based on 2024 Medicare Part D data, Luis Camacho, M.D., MPH's most frequently prescribed drugs include Abiraterone Acetate, Prednisone, Eliquis. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Luis Camacho, M.D., MPH accept Medicare?
Luis Camacho, M.D., MPH appears in CMS Medicare data with 667 Part D claims and 83 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Luis Camacho, M.D., MPH's credentials?
Luis Camacho, M.D., MPH's NPI is 1336249960 with credentials M.D., MPH. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

View source datasets and methodology notes
Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.